scispace - formally typeset
J

Jerome Korzelius

Researcher at National Institutes of Health

Publications -  20
Citations -  2674

Jerome Korzelius is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cellular differentiation & Adult stem cell. The author has an hindex of 13, co-authored 19 publications receiving 2191 citations. Previous affiliations of Jerome Korzelius include Heidelberg University & University of Kent.

Papers
More filters
Journal ArticleDOI

NPR1 Modulates Cross-Talk between Salicylate- and Jasmonate-Dependent Defense Pathways through a Novel Function in the Cytosol

TL;DR: Analysis of the Arabidopsis mutant npr1 revealed that the antagonistic effect of SA on JA signaling requires the regulatory protein NPR1, indicating that cross-talk between SA and JA is modulated through a novel function of NPR1 in the cytosol.
Journal ArticleDOI

The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies

Claire Redin, +179 more
- 01 Jan 2017 - 
TL;DR: It is proposed that sequence-level resolution dramatically improves prediction of clinical outcomes for balanced rearrangements and provides insight into new pathogenic mechanisms, such as altered regulation due to changes in chromosome topology.
Journal ArticleDOI

Fly-FUCCI: A Versatile Tool for Studying Cell Proliferation in Complex Tissues

TL;DR: The development of a Drosophila-specific FUCCI system (Fly-FUCCI) that allows one to distinguish G1, S, and G2 phases of interphase and should be a valuable tool for visualizing cell-cycle activity during development, tissue homeostasis, and neoplastic growth.
Journal ArticleDOI

Herbivore-induced resistance against microbial pathogens in Arabidopsis

TL;DR: Pharmacological experiments showed that ET acts synergistically on SA-induced PR-1, suggesting that the increased production of ET upon herbivore feeding sensitizes the tissue to respond faster to SA, thereby contributing to an enhanced defensive capacity toward pathogens, such as TCV, that trigger SA-dependent defenses upon infection.